At-Home Genetic Testing Market Report 2026

The at-home genetic testing market size has grown rapidly in recent years. It will grow from $4.02 billion in 2025 to $4.66 billion in 2026 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to increasing consumer interest in personalized health insights, declining costs of genetic sequencing, expansion of online health platforms, growing awareness of hereditary disease risks, availability of easy-to-use home sampling kits.

The at-home genetic testing market size is expected to see rapid growth in the next few years. It will grow to $8.29 billion in 2030 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to increasing integration of genetic data with digital health platforms, rising demand for preventive healthcare solutions, expansion of personalized nutrition and fitness planning, growing regulatory clarity around DTC testing, advancements in genomic data analytics. Major trends in the forecast period include increasing adoption of direct-to-consumer genetic health kits, rising demand for ancestry and ethnicity analysis, growing use of pharmacogenomic testing, expansion of personalized wellness insights, enhanced focus on data privacy and consent.

The growing adoption of telehealth is expected to drive the growth of the at-home genetic testing market going forward. Telehealth refers to the use of digital communication and information technologies, including computers, smartphones, and video conferencing, to deliver and manage healthcare services remotely. Its increasing adoption is fueled by the convenience it offers and its ability to expand access to healthcare, particularly for individuals in remote, rural, or underserved regions. At-home genetic testing complements telehealth by providing personalized genetic insights that healthcare providers can utilize during virtual consultations. This information enables doctors to tailor treatment plans, manage chronic conditions, and deliver precise health recommendations remotely. For instance, in November 2025, according to the Australian Bureau of Statistics (ABS), an Australia-based government statistical agency, 22.5% of Australians used telehealth services in 2024-25. Among those who had a telehealth consultation, 90.3% indicated they would use telehealth again if offered, up from 89.2% in 2023-24, reflecting growing acceptance and continued adoption. Therefore, the expanding use of telehealth is fueling the growth of the at-home genetic testing market.

Key companies in the at-home genetic testing market are increasingly emphasizing innovative solutions such as health membership models to deliver continuous, personalized preventive care. Health membership models are subscription-based programs providing ongoing access to services such as advanced genetic testing, routine biomarker monitoring, and virtual clinician consultations, enabling users to track health risks consistently and receive customized prevention plans. For instance, in November 2023, 23andMe, a US-based personal genomics company, launched 23andMe+ Total Health, a membership program offering clinical-grade exome sequencing of over 100 medically relevant genes associated with more than 55 health conditions, biannual testing for 55+ blood biomarkers, and virtual consultations with genetics-trained clinicians. This service integrates advanced genetic insights with continuous monitoring and telehealth support, evolving at-home genetic testing from a one-time product into an ongoing preventive health solution.

In February 2025, Tempus AI Inc., a US-based health technology company, acquired Ambry Genetics Corporation for an undisclosed amount. This acquisition aims to strengthen Tempus’ precision medicine capabilities by leveraging Ambry Genetics’ expertise in genetic testing to enhance AI-driven diagnostics and patient care. Ambry Genetics is a US-based biotechnology company specializing in clinical-grade genetic testing.

Major companies operating in the at-home genetic testing market are AncestryDNA, LetsGetChecked, Helix OpCo LLC, Everlywell Inc., Genos Inc., Vitagene Inc., Orig3n Inc., Mapmygenome India Limited, CircleDNA, EasyDNA Limited, African Ancestry Inc., Futura Genetics Ltd., Living DNA Ltd., Nebula Genomics Inc., TellmeGen S.L., Xcode Life Sciences Pvt Ltd., Color Health Inc., MyHeritage Ltd, FamilyTreeDNA (Gene By Gene Ltd), Color Genomics Inc, DNAfit, Pathway Genomics Inc.

North America was the largest region in the at-home genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the at-home genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the at-home genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the at-home genetic testing market by increasing costs of imported sequencing reagents, testing cartridges, laboratory instruments, and data processing hardware used in sample analysis workflows. North America and Europe are most affected due to dependence on specialized imported consumables, while Asia-Pacific faces cost pressures in kit manufacturing and logistics. These tariffs are raising operational expenses and influencing test pricing strategies. However, they are also encouraging localized reagent production, regional laboratory expansion, and investment in domestic genomics infrastructure, supporting long-term supply chain resilience.

The at-home genetic testing market research report is one of a series of new reports that provides at-home genetic testing market statistics, including at-home genetic testing industry global market size, regional shares, competitors with a at-home genetic testing market share, detailed at-home genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the at-home genetic testing industry. This at-home genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

At-home genetic testing, also known as direct-to-consumer (DTC) genetic testing, refers to kits that allow individuals to collect their DNA samples - typically through saliva or a cheek swab - conveniently from home. These tests analyze genetic information to provide insights into ancestry, health risks, traits, or carrier status for inherited conditions, enabling personalized decisions regarding health and lifestyle.

The primary test types of at-home genetic testing include ancestry testing, health and wellness testing, disease risk assessment, carrier testing, and others. Ancestry testing examines a person’s DNA to identify their ancestral origins and ethnic background. These tests utilize technologies such as next-generation sequencing, polymerase chain reaction (PCR), microarray, and others, with common sample types including saliva, blood, cheek swab, urine, and more. At-home genetic testing is applied for personal use, clinical purposes, research, pharmaceutical applications, and nutritional guidance, and is distributed through various channels, including online platforms, retail pharmacies, and others.

The at-home genetic testing market consists of revenues earned by entities by providing services such as skin and aging DNA analysis, exome sequencing, and relationship testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The at-home genetic testing market also includes sales of whole genome sequencing kits, saliva collection kits, and hair sample kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.